Pancreatic Neuroendocrine Tumors
625 articles
Drama Helps Playwright Tackle Pancreatic Cancer Loss
Playwright Isobel Barrett has turned the tragic loss of her husband into a moving play that is also a tool for pancreatic cancer advocacy.
Reopening America: Guidelines For Pancreatic Cancer Patients
As states begin to reopen their economies, the threat of COVID-19 remains. Dr. Allyson Ocean has recommendations for pancreatic cancer patients.
COVID-19 and Pancreatic Cancer Clinical Trials
How is the COVID-19 pandemic affecting clinical trials? Learn more about what steps are being taken to protect patients on trials, plus more.
Testing Targeted Immunotherapy Against Pancreatic Cancer
Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.
Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer
A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.
Testing a Different Approach to Pancreatic Cancer Treatment
A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.
Facebook Live: Why Is Pancreatic Cancer Research Important?
Dr. David Tuveson and Dr. Allyson Ocean discuss the importance of pancreatic cancer research in this video of a Facebook Live chat.
Facebook Live: Early Detection of Pancreatic Cancer
Dr. Anirban Maitra and Dr. Allyson Ocean discuss the status of tests to provide early detection of pancreatic cancer in this video of a Facebook Live chat.
Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Let’s Win! Pancreatic Cancer Foundation Appoints Two New Board Members
David Glauber and Sergeant Elvin Howard, Jr., have been appointed to the Let’s Win Board of Directors, effective July 2020.